ReviewInternational journal of medical sciences2022

Empagliflozin in the treatment of heart failure and type 2 diabetes mellitus: Evidence from several large clinical trials.

Bo Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.